A detailed history of Price T Rowe Associates Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,889,119 shares of SANA stock, worth $7.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,889,119
Previous 3,117,996 7.34%
Holding current value
$7.54 Million
Previous $17 Million 29.41%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.76 - $6.86 $860,577 - $1.57 Million
-228,877 Reduced 7.34%
2,889,119 $12 Million
Q2 2024

Aug 14, 2024

SELL
$5.23 - $10.44 $3.02 Million - $6.03 Million
-577,463 Reduced 15.63%
3,117,996 $17 Million
Q1 2024

May 15, 2024

BUY
$4.2 - $11.27 $426,022 - $1.14 Million
101,434 Added 2.82%
3,695,459 $37 Million
Q4 2023

Feb 14, 2024

SELL
$2.8 - $4.55 $9.61 Million - $15.6 Million
-3,432,116 Reduced 48.85%
3,594,025 $14.7 Million
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $7.17 Million - $11.9 Million
1,902,713 Added 37.14%
7,026,141 $27.2 Million
Q2 2023

Aug 14, 2023

BUY
$3.22 - $7.53 $1.97 Million - $4.61 Million
612,642 Added 13.58%
5,123,428 $30.5 Million
Q1 2023

May 15, 2023

BUY
$3.11 - $4.92 $765,974 - $1.21 Million
246,294 Added 5.78%
4,510,786 $14.8 Million
Q4 2022

Feb 14, 2023

BUY
$3.19 - $6.46 $1.99 Million - $4.03 Million
623,989 Added 17.14%
4,264,492 $16.8 Million
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $4.18 Million - $6.77 Million
748,922 Added 25.9%
3,640,503 $21.8 Million
Q2 2022

Aug 15, 2022

BUY
$4.12 - $9.35 $3.47 Million - $7.87 Million
841,448 Added 41.04%
2,891,581 $18.6 Million
Q1 2022

May 16, 2022

BUY
$5.24 - $15.58 $4.43 Million - $13.2 Million
845,437 Added 70.18%
2,050,133 $16.9 Million
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $266,970 - $407,139
17,587 Added 1.48%
1,204,696 $18.6 Million
Q3 2021

Nov 15, 2021

SELL
$16.29 - $25.88 $50,336 - $79,969
-3,090 Reduced 0.26%
1,187,109 $26.7 Million
Q2 2021

Aug 16, 2021

SELL
$16.65 - $32.14 $274,908 - $530,663
-16,511 Reduced 1.37%
1,190,199 $23.4 Million
Q1 2021

May 17, 2021

BUY
$23.04 - $43.5 $27.8 Million - $52.5 Million
1,206,710 New
1,206,710 $40.4 Million

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $497M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.